Get startedLog in
    Picture of LINCOLN PHARMACEUTICALS logo

    531633 — LINCOLN PHARMACEUTICALS Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for LINCOLN PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line8379591,0051,2221,092
    Depreciation
    Non-Cash Items-24.6-58.8-85.6-278-75.3
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-196-220-618-419-215
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities693761393632930
    Capital Expenditures-87.5-455-143-396-192
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-555-326-224-177-597
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-642-781-366-573-789
    Financing Cash Flow Items-11.9-10.4-13.5-12.7-18
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-57.5-25.6-45-51.8-64
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-7.03-45-18.86.9576.7